# Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50

> **NCT06069687** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **The Hospital for Sick Children** · enrollment: 1 (actual)

## Conditions studied

- Spastic Paraplegia Type 50

## Interventions

- **BIOLOGICAL:** MELPIDA

## Key facts

- **NCT ID:** NCT06069687
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-03-11
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06069687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06069687, "Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06069687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*